News
An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...
On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...
Health and Me on MSN4d
FDA Panel Questions Antidepressant Safety For Pregnant Women; Can SSRIs Harm Unborn Babies?
When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...
At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...
Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...
Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...
A Food and Drug Administration panel on Monday discussing the use of antidepressants during pregnancy largely amounted to ...
As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
The medication would also be much handier than other treatments. Currently, there's only one drug on the market that's FDA-approved to treat postpartum depression.The drug, called Zulresso, is ...
NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback